Newport Beach, CANCT07453888Now EnrollingIRB Ready

Non-Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial in Newport Beach, CA

Access cutting-edge non-arteritic anterior ischemic optic neuropathy treatment through this clinical trial at a research site in Newport Beach. Study-provided care at no cost to qualified participants.

Sponsored by Dompé Farmaceutici S.p.A

Quick Self-Assessment

See if you qualify for this Newport Beach location

Preparing your pre-screening questions…

Expert Care in Newport Beach

Access non-arteritic anterior ischemic optic neuropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-arteritic anterior ischemic optic neuropathy treatment provided free

Apply for This Newport Beach Location

Check if you qualify for this non-arteritic anterior ischemic optic neuropathy clinical trial in Newport Beach, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Newport Beach

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Newport Beach site if eligible
  4. 4Begin participation

About This Non-Arteritic Anterior Ischemic Optic Neuropathy Study in Newport Beach

This is a phase 3, randomized, multicenter, vehicle-controlled, double-masked study to evaluate the efficacy and safety of intranasal cenegermin compared with vehicle control in adult participants with NAION. Approximately 272 participants who meet all eligibility criteria will be randomly assigned in a 1:1 ratio to receive either cenegermin treatment (Group 1) or the vehicle control (Group 2).

Sponsor: Dompé Farmaceutici S.p.A

Who Can Participate

Inclusion Criteria

A clinical diagnosis of unilateral NAION in the study eye with symptom onset within 14 days prior to the planned date for first dose administration.
A BCVA score in the study eye of ≥ 15 letters and ≤ 65 letters measured using the ETDRS chart.
Sufficiently clear ocular media and adequate pupil dilation to enable assessment of the optic nerve and retina in both eyes. Key

Exclusion Criteria

Bilateral NAION or sequential NAION with fellow eye involvement within 6 weeks of study eye involvement.
Clinical evidence of temporal arteritis (giant cell arteritis) signs or symptoms.
Abnormal laboratory findings suggestive of temporal arteritis (giant cell arteritis), in the absence of a known acute cause
Pain with eye movement
Intraocular pressure (IOP) greater than 25 mmHg in the study eye or history of glaucoma in the study eye.
Intermediate age-related macular degeneration (AMD) with subfoveal drusen, exudative AMD, or geographic atrophy in the study eye. Note: Additional inclusion/exclusion criteria apply, as defined in the protocol.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Newport Beach?

Yes, this clinical trial (NCT07453888) has an active research site in Newport Beach, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-Arteritic Anterior Ischemic Optic Neuropathy Treatment Options in Newport Beach, CA

If you're searching for non-arteritic anterior ischemic optic neuropathy treatment options in Newport Beach, CA, this clinical trial (NCT07453888) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Newport Beach research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-arteritic anterior ischemic optic neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-arteritic anterior ischemic optic neuropathy clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Newport Beach, CA

See all heart attack clinical trials recruiting in Newport Beach — not just this study.

Browse Heart Attack Trials in Newport Beach

Ready to Join in Newport Beach?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Newport Beach, CA